Australian guidelines for anal cancer screening using anal human papillomavirus testing with cytology triage in people living with HIV
HIV Medicine · 2025
DOI: 10.1111/hiv.70133 ↗Kurz gefasst
Leitlinie in der Zeitschrift HIV Medicine, 2025. Verfasst von I M Poynten und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Anus Neoplasms, HIV Infections, Papillomavirus Infections, Early Detection of Cancer. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: ASHM Health.
Abstract (Originalsprache)
Objectives
To develop Australian anal cancer screening guidelines for people living with HIV.
Methods
In 2023, ASHM Health assembled a committee to create guidelines, based on existing international guidelines and utilizing data from the Study of the Prevention of Anal Cancer (SPANC). SPANC provided Australian‐specific data on different screening methodologies for the detection of anal high‐grade squamous intraepithelial lesions.
Results
The guidelines were released in March 2025. They recommend primary high‐risk human papillomavirus (HRHPV) testing with cytology triage for high‐resolution anoscopy. Gay, bisexual and other men who have sex with men (GBM) and trans‐women living with HIV should be offered screening from 35 years of age. Cis‐women, trans‐men and other cis‐men (not GBM) living with HIV should be offered screening from 45 years of age. All anal cancer screening should include annual digital ano‐rectal examination, examination of the peri‐anal region and a thorough medical history. Screening should be repeated every 3 years for those who screen negative. Screening should be discontinued, with shared decision‐making, at age 75 years and/or in individuals with two consecutive negative screening visits who are not currently sexually active.
Conclusions
These are the first guidelines to recommend primary HRHPV testing with cytology triage as the screening modality. They will assist clinicians in identifying and screening people living with HIV at higher risk of anal cancer and will enable screening and referral of people living with HIV at highest risk for high‐resolution anoscopy, while screening and treatment services capacity are expanded in Australia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
- School of Medicine, University of Tasmania, Hobart, Tasmania, Australia.
- Sydney Sexual Health Centre, Sydney, New South Wales, Australia.
- Positive Life NSW, Sydney, New South Wales, Australia.
- Dysplasia and Anal Cancer Services, St Vincent's Hospital, Sydney, New South Wales, Australia.
- School of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.
ORCID-Profile: I M Poynten, R C Turner, J Hoy
Förderung
- ASHM Health
Zitieren
APA
Poynten, I. M., Turner, R. C., Varma, R., Costello, J., Hillman, R. J., McCloskey, J., Ong, J. J., Sever, Z., Givan, J., Armstrong, B., Clifton, B., Koh, K., Elliott, S., Bloch, M., Hoy, J., Grulich, A. E., & Roberts, J. M. (2025). Australian guidelines for anal cancer screening using anal human papillomavirus testing with cytology triage in people living with HIV. HIV Medicine. https://doi.org/10.1111/hiv.70133
Vancouver
Poynten IM, Turner RC, Varma R, Costello J, Hillman RJ, McCloskey J, et al. Australian guidelines for anal cancer screening using anal human papillomavirus testing with cytology triage in people living with HIV. HIV Medicine. 2025. doi:10.1111/hiv.70133
BibTeX
@article{Poynten2025,
author = {Poynten, I M and Turner, R C and Varma, R and Costello, J and Hillman, R J and McCloskey, J and Ong, J J and Sever, Z and Givan, J and Armstrong, B and Clifton, B and Koh, K and Elliott, S and Bloch, M and Hoy, J and Grulich, A E and Roberts, J M},
title = {Australian guidelines for anal cancer screening using anal human papillomavirus testing with cytology triage in people living with HIV},
journal = {HIV Medicine},
year = {2025},
doi = {10.1111/hiv.70133}
}
EUVIMED